Penile Treatment Shows Promise in Phase 3 TrialsPenile Treatment Shows Promise in Phase 3 Trials

Collagenase Clostridium histolyticum can reduce symptoms of Peyronie's disease, investigators report. Medscape Medical News

Source: Medscape Today Headlines - May 7, 2013 Category: Consumer Health News Tags: Urology News Source Type: news